Last updated on August 2010

Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)


Brief description of study

To assess the efficacy and toxicity of plerixafor (AMD 3100) together with granulocyte-colony stimulating factor (G-CSF) for stem cell mobilisation, in patients with myeloma or lymphoma requiring high dose chemotherapy with stem cell rescue.

Clinical Study Identifier: NCT01186224

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Richard E Clark, BA, MB, ...

Dept of Haematology, University of Liverpool
Liverpool, United Kingdom
  Connect »